Clinical Trial Update: Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety, tolerability and pharmacokinetics of AIN457 in rheumatoid arthritis patients, a Phase 1/2 study that has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-30